Concepts (107)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Tomography, X-Ray Computed | 8 | 2025 | 1663 | 1.080 |
Why?
|
| Neuroimaging | 2 | 2025 | 170 | 0.940 |
Why?
|
| Brain Diseases | 1 | 2025 | 76 | 0.830 |
Why?
|
| Neck Injuries | 2 | 2016 | 18 | 0.830 |
Why?
|
| Magnetic Resonance Imaging | 8 | 2025 | 2325 | 0.760 |
Why?
|
| Multiple Sclerosis | 2 | 2025 | 227 | 0.750 |
Why?
|
| Cerebral Angiography | 3 | 2020 | 303 | 0.750 |
Why?
|
| Computed Tomography Angiography | 2 | 2021 | 143 | 0.740 |
Why?
|
| Blood Coagulation Disorders | 1 | 2022 | 23 | 0.700 |
Why?
|
| Hemorrhage | 1 | 2022 | 287 | 0.610 |
Why?
|
| Emergency Service, Hospital | 3 | 2025 | 1165 | 0.610 |
Why?
|
| Artificial Intelligence | 1 | 2023 | 216 | 0.600 |
Why?
|
| Brain | 4 | 2025 | 1672 | 0.600 |
Why?
|
| Radiology | 1 | 2023 | 263 | 0.580 |
Why?
|
| Wounds, Nonpenetrating | 1 | 2018 | 116 | 0.500 |
Why?
|
| Cerebrovascular Circulation | 1 | 2018 | 228 | 0.480 |
Why?
|
| Neck Muscles | 1 | 2016 | 10 | 0.480 |
Why?
|
| Brain Injuries | 1 | 2018 | 141 | 0.480 |
Why?
|
| Diagnostic Imaging | 1 | 2018 | 274 | 0.440 |
Why?
|
| Skull Fractures | 1 | 2015 | 20 | 0.440 |
Why?
|
| Intracranial Hypotension | 1 | 2014 | 14 | 0.410 |
Why?
|
| Diffusion Tensor Imaging | 1 | 2013 | 81 | 0.380 |
Why?
|
| Cerebral Infarction | 1 | 2013 | 88 | 0.370 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2015 | 312 | 0.360 |
Why?
|
| Stroke | 2 | 2021 | 1226 | 0.360 |
Why?
|
| Ligaments | 1 | 2012 | 9 | 0.360 |
Why?
|
| Spinal Injuries | 1 | 2012 | 11 | 0.360 |
Why?
|
| Soft Tissue Injuries | 1 | 2012 | 20 | 0.350 |
Why?
|
| Cervical Vertebrae | 1 | 2012 | 122 | 0.320 |
Why?
|
| Sensitivity and Specificity | 6 | 2015 | 1172 | 0.310 |
Why?
|
| Humans | 20 | 2025 | 65872 | 0.290 |
Why?
|
| Magnetic Resonance Angiography | 2 | 2014 | 202 | 0.250 |
Why?
|
| Pheochromocytoma | 1 | 2007 | 32 | 0.250 |
Why?
|
| Middle Aged | 10 | 2025 | 18518 | 0.250 |
Why?
|
| Adrenal Gland Neoplasms | 1 | 2007 | 53 | 0.240 |
Why?
|
| Inflammation | 2 | 2025 | 1196 | 0.240 |
Why?
|
| Adipose Tissue, Brown | 1 | 2007 | 126 | 0.230 |
Why?
|
| Male | 13 | 2025 | 31435 | 0.230 |
Why?
|
| Radiography, Dual-Energy Scanned Projection | 1 | 2025 | 5 | 0.230 |
Why?
|
| Female | 12 | 2025 | 34459 | 0.220 |
Why?
|
| Reproducibility of Results | 5 | 2021 | 1720 | 0.210 |
Why?
|
| Retrospective Studies | 6 | 2025 | 6956 | 0.210 |
Why?
|
| Gadolinium | 1 | 2025 | 111 | 0.200 |
Why?
|
| Angiography, Digital Subtraction | 2 | 2014 | 141 | 0.190 |
Why?
|
| Contrast Media | 4 | 2025 | 435 | 0.190 |
Why?
|
| Artifacts | 2 | 2014 | 130 | 0.190 |
Why?
|
| Image Interpretation, Computer-Assisted | 2 | 2014 | 190 | 0.180 |
Why?
|
| Radiologists | 1 | 2023 | 95 | 0.180 |
Why?
|
| Vertebrobasilar Insufficiency | 1 | 2012 | 27 | 0.170 |
Why?
|
| Intracranial Hemorrhages | 1 | 2022 | 71 | 0.170 |
Why?
|
| Hematoma | 1 | 2022 | 85 | 0.170 |
Why?
|
| Cerebral Hemorrhage | 1 | 2022 | 100 | 0.170 |
Why?
|
| Collateral Circulation | 1 | 2020 | 28 | 0.160 |
Why?
|
| Aged | 7 | 2021 | 15155 | 0.160 |
Why?
|
| Ultrasonography, Doppler, Duplex | 1 | 2021 | 48 | 0.160 |
Why?
|
| Carotid Stenosis | 1 | 2021 | 100 | 0.150 |
Why?
|
| Diagnosis, Differential | 3 | 2014 | 993 | 0.150 |
Why?
|
| Image Enhancement | 2 | 2013 | 196 | 0.140 |
Why?
|
| Algorithms | 1 | 2023 | 1059 | 0.130 |
Why?
|
| Adult | 6 | 2025 | 17595 | 0.120 |
Why?
|
| Sinus Pericranii | 1 | 2014 | 4 | 0.100 |
Why?
|
| Ki-67 Antigen | 1 | 2014 | 37 | 0.100 |
Why?
|
| Scalp | 1 | 2014 | 30 | 0.100 |
Why?
|
| Meningeal Neoplasms | 1 | 2014 | 63 | 0.100 |
Why?
|
| Meningioma | 1 | 2014 | 65 | 0.100 |
Why?
|
| Veins | 1 | 2014 | 63 | 0.100 |
Why?
|
| Aneurysm, False | 1 | 2014 | 47 | 0.100 |
Why?
|
| Hair | 1 | 2014 | 81 | 0.100 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 1 | 2014 | 172 | 0.100 |
Why?
|
| Head | 1 | 2013 | 57 | 0.090 |
Why?
|
| Intracranial Aneurysm | 2 | 2014 | 384 | 0.090 |
Why?
|
| Cerebrovascular Disorders | 1 | 2013 | 89 | 0.090 |
Why?
|
| Analysis of Variance | 1 | 2013 | 606 | 0.090 |
Why?
|
| Case-Control Studies | 1 | 2014 | 1150 | 0.080 |
Why?
|
| Biomarkers, Tumor | 1 | 2014 | 527 | 0.080 |
Why?
|
| Gastrointestinal Stromal Tumors | 1 | 2009 | 20 | 0.070 |
Why?
|
| Piperazines | 1 | 2009 | 86 | 0.070 |
Why?
|
| Pyrimidines | 1 | 2009 | 144 | 0.070 |
Why?
|
| Radiographic Image Enhancement | 1 | 2007 | 99 | 0.060 |
Why?
|
| Follow-Up Studies | 2 | 2014 | 2500 | 0.060 |
Why?
|
| Child | 1 | 2015 | 4656 | 0.050 |
Why?
|
| Aged, 80 and over | 3 | 2021 | 5684 | 0.050 |
Why?
|
| Antineoplastic Agents | 1 | 2009 | 645 | 0.050 |
Why?
|
| Adolescent | 1 | 2015 | 6371 | 0.050 |
Why?
|
| Predictive Value of Tests | 2 | 2021 | 1117 | 0.050 |
Why?
|
| Machine Learning | 1 | 2025 | 197 | 0.050 |
Why?
|
| Age Distribution | 1 | 2012 | 262 | 0.040 |
Why?
|
| Risk Factors | 2 | 2021 | 5477 | 0.040 |
Why?
|
| Longitudinal Studies | 1 | 2025 | 1299 | 0.040 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 1 | 2021 | 76 | 0.040 |
Why?
|
| Clinical Decision-Making | 1 | 2021 | 170 | 0.040 |
Why?
|
| Prevalence | 1 | 2012 | 1455 | 0.030 |
Why?
|
| Databases, Factual | 1 | 2021 | 889 | 0.030 |
Why?
|
| Prognosis | 1 | 2021 | 1793 | 0.030 |
Why?
|
| Severity of Illness Index | 1 | 2021 | 1570 | 0.030 |
Why?
|
| Neoplasm Grading | 1 | 2014 | 102 | 0.030 |
Why?
|
| Risk Assessment | 1 | 2021 | 2116 | 0.030 |
Why?
|
| Statistics as Topic | 1 | 2014 | 147 | 0.020 |
Why?
|
| Cerebral Arteries | 1 | 2014 | 45 | 0.020 |
Why?
|
| Venous Thrombosis | 1 | 2013 | 113 | 0.020 |
Why?
|
| Young Adult | 1 | 2012 | 4887 | 0.020 |
Why?
|
| Imatinib Mesylate | 1 | 2009 | 34 | 0.020 |
Why?
|
| Benzamides | 1 | 2009 | 69 | 0.020 |
Why?
|
| Infant | 1 | 2014 | 1721 | 0.020 |
Why?
|
| United States | 1 | 2012 | 8192 | 0.020 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2009 | 378 | 0.020 |
Why?
|
| Disease Progression | 1 | 2009 | 1231 | 0.010 |
Why?
|